Chen-ta Chi
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
An in-hospital referral program for hepatitis c virus elimination in patients with type 2 diabetes mellitus.
Journal: Journal of the Chinese Medical Association : JCMA
Published: July 21, 2026
Optimal treatment selection for hepatocellular carcinoma in the era of immunotherapy.
Journal: Journal of gastroenterology
Published: February 10, 2026
Distinct gut microbiota but common metabolomic signatures between viral and MASLD HCC contribute to outcomes of combination immunotherapy.
Journal: Hepatology (Baltimore, Md.)
Published: April 09, 2025
Characterizing immune profiles in hepatocellular carcinoma patients benefiting from pembrolizumab and lenvatinib using machine learning.
Journal: BMC cancer
Published: March 31, 2025
Effect of immune checkpoint inhibitors on patients with hepatitis B virus infection.
Journal: Journal of the Chinese Medical Association : JCMA
Published: December 27, 2024
Diabetes Mellitus Negatively Impacts Outcomes of HBV-Related Hepatocellular Carcinoma Following Thermal Ablation.
Journal: Journal of hepatocellular carcinoma
Published: July 23, 2024
Impact of HCV eradication on recurrence pattern and long-term outcomes in patients with HCV-related hepatocellular carcinoma undergoing radiofrequency ablation.
Journal: Alimentary pharmacology & therapeutics
Published: April 29, 2024
Analyzing risk factors and developing a stratification system for hepatocellular carcinoma recurrence after interferon-free direct-acting antiviral therapy in chronic hepatitis C patients.
Journal: Journal of the Chinese Medical Association : JCMA
Published: January 05, 2024
Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapy.
Journal: Journal of hepatology
Published: January 04, 2024
Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma.
Journal: Liver cancer
Published: December 20, 2022
Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment.
Journal: Viruses
Published: September 29, 2022
Last Updated: 09/26/2026